Follow
Frances Lennon
Title
Cited by
Cited by
Year
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation
B Mathew, FE Lennon, J Siegler, T Mirzapoiazova, N Mambetsariev, ...
Anesthesia & Analgesia 112 (3), 558-567, 2011
2862011
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer
FE Lennon, T Mirzapoiazova, B Mambetsariev, VA Poroyko, R Salgia, ...
PloS one 9 (3), e91577, 2014
2002014
Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea
I Almendros, Y Wang, L Becker, FE Lennon, J Zheng, BR Coats, ...
American journal of respiratory and critical care medicine 189 (5), 593-601, 2014
1932014
Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea
I Almendros, Y Wang, L Becker, FE Lennon, J Zheng, BR Coats, ...
American journal of respiratory and critical care medicine 189 (5), 593-601, 2014
1932014
Hyaluronan regulation of vascular integrity
FE Lennon, PA Singleton
American journal of cardiovascular disease 1 (3), 200, 2011
1932011
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis
FE Lennon, T Mirzapoiazova, B Mambetsariev, R Salgia, J Moss, ...
The Journal of the American Society of Anesthesiologists 116 (4), 857-867, 2012
1902012
The μ-opioid receptor in cancer progression: is there a direct effect?
FE Lennon, J Moss, PA Singleton, B Riou
The Journal of the American Society of Anesthesiologists 116 (4), 940-945, 2012
1822012
The μ-opioid receptor in cancer progression: is there a direct effect?
FE Lennon, J Moss, PA Singleton, B Riou
The Journal of the American Society of Anesthesiologists 116 (4), 940-945, 2012
1822012
Lung cancer—a fractal viewpoint
FE Lennon, GC Cianci, NA Cipriani, TA Hensing, HJ Zhang, CT Chen, ...
Nature reviews Clinical oncology 12 (11), 664-675, 2015
1752015
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation
L Faoro, PA Singleton, GM Cervantes, FE Lennon, NW Choong, R Kanteti, ...
Journal of biological chemistry 285 (24), 18575-18585, 2010
1362010
Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology
FE Lennon, PA Singleton
American Journal of Physiology-Lung Cellular and Molecular Physiology 301 (2 …, 2011
1332011
FAK and paxillin, two potential targets in pancreatic cancer
R Kanteti, SK Batra, FE Lennon, R Salgia
Oncotarget 7 (21), 31586, 2016
1132016
High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness
PA Singleton, T Mirzapoiazova, Y Guo, S Sammani, N Mambetsariev, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 299 (5 …, 2010
1072010
Hyaluronic acid binding protein 2 is a novel regulator of vascular integrity
N Mambetsariev, T Mirzapoiazova, B Mambetsariev, S Sammani, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (3), 483-490, 2010
1042010
Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and cell proliferation in human vascular endothelial cells
JF Murphy, F Lennon, C Steele, D Kelleher, D Fitzgerald, A Long
The FASEB journal 19 (3), 1-17, 2005
952005
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma
R Kanteti, I Dhanasingh, I Kawada, FE Lennon, Q Arif, R Bueno, R Hasina, ...
PloS one 9 (9), e105919, 2014
682014
Mitochondrial dynamics: biology and therapy in lung cancer
FE Lennon, R Salgia
Expert opinion on investigational drugs 23 (5), 675-692, 2014
542014
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer
I Kawada, R Hasina, FE Lennon, VP Bindokas, P Usatyuk, YHC Tan, ...
Cancer biology & therapy 14 (7), 679-691, 2013
452013
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
FE Lennon, GC Cianci, R Kanteti, JJ Riehm, Q Arif, VA Poroyko, ...
Scientific reports 6 (1), 24578, 2016
412016
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression
FE Lennon, T Mirzapoiazova, N Mambetsariev, B Mambetsariev, R Salgia, ...
Journal of Biological Chemistry 289 (35), 24043-24058, 2014
412014
The system can't perform the operation now. Try again later.
Articles 1–20